Clinical Trial: Efficacy and Safety of Attapulgite in Patients With Obesity: An Exploratory Clinical Trial

U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07103382) titled 'Efficacy and Safety of Attapulgite in Patients With Obesity: An Exploratory Clinical Trial' on July 10.

Brief Summary: To explore the safety and efficacy of attapulgite in the treatment of obese individuals or overweight/obese individuals with type 2 diabetes.

Study Start Date: Aug., 2025

Study Type: INTERVENTIONAL

Condition: Obesity

Intervention: DIETARY_SUPPLEMENT: Attapulgite

Participants were administered daily attapulgite (2.5 g) for a duration of 12 weeks.

DIETARY_SUPPLEMENT: Placebo

Participants were administered daily maltodextrin (2.5 g) for a duration of 12 weeks.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: S...